EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gender and melanoma subtype‐based prognostic implications of MUC16 and TTN co‐occurrent mutations in melanoma: A retrospective multi‐study analysis

Nilesh Kodali iD, Simona Alomary, Abhijit Bhattaru, Ahmed Eldaboush, Robert A Schwartz, Shari R Lipner

Cancer Medicine · 2024

DOI: 10.1002/cam4.70199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Nilesh Kodali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers New Jersey Medical School, Newark, New Jersey, USA. Hauptthemen laut MEDLINE: Melanoma, Mutation, Skin Neoplasms, Connectin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Most primary cutaneous melanomas have pathogenesis driven by ultraviolet exposure and genetic mutations, whereas acral lentiginous melanoma (ALM) and metastatic melanoma are much less, if at all, linked with the former. Thus, we evaluated both ultraviolet related and non‐ultraviolet related melanomas. Mutations in the MUC16 and TTN genes commonly occur concurrently in these melanoma patients, but their combined prognostic significance stratified by gender and cancer subtype remains unclear.

Methods

The cBioPortal database was queried for melanoma studies and returned 16 independent studies. Data from 2447 melanoma patients were utilized including those with ALM, cutaneous melanoma (CM), and melanoma of unknown primary (MUP). Patients were grouped based on the presence or absence of MUC16 and TTN mutations. Univariate Cox regression and Student's t ‐tests were used to analyze hazard ratios and total mutation count comparisons, respectively.

Results

TTN mutations, either alone or concurrently with MUC16 mutations, significantly correlated with worse prognosis overall, in both genders, and in CM patients. ALM patients with both mutations had better prognoses than CM patients, while ALM patients with neither mutation had worse prognosis than CM patients. For MUP patients, only MUC16 mutations correlated with worse prognosis. ALM patients with neither MUC16 nor TTN mutations had significantly more total mutations than MUP patients, followed by CM patients.

Conclusion

TTN mutations are a potential marker of poor prognosis in melanoma, which is amplified in the presence of concurrent MUC16 mutations. ALM patients with neither gene mutations had worse prognosis, suggesting a protective effect of having both MUC16 and TTN mutations. Only MUC16 mutations conferred a worse prognosis for MUP patients. Comprehensive genetic profiling in melanoma patients may facilitate personalized treatment strategies to optimize patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaMutationSkin NeoplasmsConnectinHumansFemaleMalePrognosisRetrospective StudiesMiddle AgedCA-125 AntigenSex FactorsMembrane ProteinsAgedBiomarkers, TumorAdult

Stichwörter der Autor:innen

MUC16TTNdemographicsmelanomasurvival outcomes

Substanzen

MUC16 protein, humanConnectinCA-125 AntigenMembrane ProteinsTTN protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Dermatology, Weill Cornell Medicine, New York, New York, USA.

ORCID-Profile: Nilesh Kodali

Zitieren

APA

Kodali, N., Alomary, S., Bhattaru, A., Eldaboush, A., Schwartz, R. A., & Lipner, S. R. (2024). Gender and melanoma subtype‐based prognostic implications of MUC16 and TTN co‐occurrent mutations in melanoma: A retrospective multi‐study analysis. Cancer Medicine. https://doi.org/10.1002/cam4.70199

Vancouver

Kodali N, Alomary S, Bhattaru A, Eldaboush A, Schwartz RA, Lipner SR. Gender and melanoma subtype‐based prognostic implications of MUC16 and TTN co‐occurrent mutations in melanoma: A retrospective multi‐study analysis. Cancer Medicine. 2024. doi:10.1002/cam4.70199

BibTeX
@article{Kodali2024,
  author = {Kodali, Nilesh and Alomary, Simona and Bhattaru, Abhijit and Eldaboush, Ahmed and Schwartz, Robert A and Lipner, Shari R},
  title = {Gender and melanoma subtype‐based prognostic implications of MUC16 and TTN co‐occurrent mutations in melanoma: A retrospective multi‐study analysis},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70199}
}
Kostenlos starten →